StockTake: EMVision expands trial for bedside stroke scanner

Stockhead’s Tylah Tully looks at the latest from EMvision Medical Devices (ASX:EMV), who have increased the sites for its pivotal trial for the emu bedside brain scanner, a device designed to rapidly diagnose stroke.

Watch the video for more.

 

This video was developed in collaboration with EMvision Medical Devices, a Stockhead advertiser at the time of publishing.

This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide